- Who we are
-
Capabilities
- Arbitration
- Banking and Finance
- Board Advisory
- Class Actions
- Competition
- Corporate Commercial
-
Employment and Labour
- Diversity and Discrimination
- Employment Contracts, Policies and Procedures
- Employment Disputes
- Executive Remuneration, Governance, Performance and Termination
- Labour Strategies, Industrial Relations and Trade Unions
- Workplace Health and Safety
- Workplace Investigations
- Team Moves and Injunctions
- Training
- Energy and Natural Resources
- Environment and Planning
-
Financial Sponsors
- Fund Formation and Management
- Pension and Sovereign Wealth Funds
- Financial Services Regulation and Superannuation
- Joint Ventures
- Public M&A
- Private M&A
- Private Equity
- Venture Capital Markets
- Special Situations Lending and Investing
- Capital Transactions and Funds
- Infrastructure Capital Transactions
- Construction and Infrastructure Projects
- Public Private Partnerships
- Tax
- Government
-
Intellectual Property
- Advertising, Marketing and Trade Promotions
- Commercialisation and Licensing
- Confidential Information
- Copyright and Designs
- Domain Name Disputes
- Franchising
- Geographical Indications
- Intellectual Property and Patent Litigation
- Misleading Conduct and Passing Off
- Patents
- Therapeutic Goods Regulation and Advertising
- Trade Marks and Branding
- Food Law
-
Investigations
- Whistleblowers and Internal Investigations
- Regulatory Investigations
- Antibribery and Corruption
- White Collar Crime and Fraud
- Royal Commissions, Inquiries and Prosecutions
- Reputation Risk Advisory
- Regulatory Compliance and Anti-Money Laundering
- Forensic Technology Investigations
- Ethics and Compliance
- Trade Investigations
- Workplace Investigations
- Litigation
- M&A and Capital Markets
- Papua New Guinea
- Projects and Construction
- Real Estate
- Responsible Business and ESG
- Restructuring, Insolvency and Special Situations
- Tax
- Technology, Media and Telecommunications
- Insights
- People
- Careers
Home
Insights
Insights
Thoughtful perspectives
Discover our latest perspectives on the big issues impacting our clients
article
Patent claims to metabolites in Australia: when will use of a prodrug be infringing?
Read More
